1-(trimethylsilyl)-1H-imidazole (TSIM)
Also Known As:
TSIM; 1-trimethylsilylimidazole; N-trimethylsilylimidizole; TMSIM
Networked: 4
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results
Experts
Related Diseases
1. | Neoplasms (Cancer)
01/05/2022
- " Recently, three molecular subtypes were proposed, the tumor-suppressor/immune-modulator (TSIM), MGA-BRDT (MB), and HDAC9-EP300-ARID1A (HEA) subtypes, and they are well-correlated with the cell of origin, EBV pattern, genomic alterations, and clinical outcomes. " 01/01/2010
- " As such, they appear as universal markers for holistic health and these may be important in the pathogenesis of cardiovascular diseases and cancer, which is the main consideration of Tsim Tsoum concept."
|
2. | Dementia (Dementias)
|
3. | Cardiovascular Diseases (Cardiovascular Disease)
|
4. | COVID-19
|
|
Related Therapies and Procedures